D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.25 MYR -0.79% Market Closed
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Duopharma Biotech Bhd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Total Current Assets
myr725.3m
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
20%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Total Current Assets
myr75.3m
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
10%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Total Current Assets
myr705.8m
CAGR 3-Years
18%
CAGR 5-Years
14%
CAGR 10-Years
13%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Total Current Assets
myr133.4m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Total Current Assets
myr374.4m
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
7%
K
Kotra Industries Bhd
KLSE:KOTRA
Total Current Assets
myr160.8m
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
5%
No Stocks Found

Duopharma Biotech Bhd
Glance View

Market Cap
1.2B MYR
Industry
Pharmaceuticals

Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.

DPHARMA Intrinsic Value
1.69 MYR
Undervaluation 26%
Intrinsic Value
Price
D

See Also

What is Duopharma Biotech Bhd's Total Current Assets?
Total Current Assets
725.3m MYR

Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Total Current Assets amounts to 725.3m MYR.

What is Duopharma Biotech Bhd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
20%

Over the last year, the Total Current Assets growth was 1%. The average annual Total Current Assets growth rates for Duopharma Biotech Bhd have been 11% over the past three years , 11% over the past five years , and 20% over the past ten years .

Back to Top